Image de couverture de livre

Real‐world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Samantha Shekar, Megan Crumbaker, Anthony Joshua, Andrew Yam, Phillip Stricker, Carlo Yuen, David Ende, Benjamin Namdarian, James Thompson, Raji Kooner, Gordon O'Neill, Jeremy Mo, Hao‐Wen Sim, George Hruby, Farshad Kasraei, Annie Ho, Jeremy De Leon
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	BJUI Compass
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
par: Ruth Pidsley, et autres
Publié: (2024)

Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
par: Jeremy Cheng, et autres
Publié: (2025)

Oncological outcomes post focal low‐dose‐rate brachytherapy in low‐intermediate risk prostate cancer
par: Mohammadmehdi Adhami, et autres
Publié: (2026)

Clinical validation of a biopsy‐based six‐gene signature prognostic for aggressive prostate cancer
par: Agnieszka Krzyzanowska, et autres
Publié: (2024)

Targeted Prostate Health Checks, a novel system to identify men with prostate cancer—A pilot study
par: Stephen Langley, et autres
Publié: (2024)

A population‐based analyses of the evolving management of cN1M0 prostate cancer in the PSMA‐PET era
par: Jennifer Ward, et autres
Publié: (2025)

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
par: Eric V. Li, et autres
Publié: (2024)

Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy
par: Maxwell Louis Sandberg, et autres
Publié: (2026)

Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
par: Eric Margolis, et autres
Publié: (2025)

PSMA PET/CT findings in high‐risk biochemical recurrence after local treatment of prostate cancer
par: Nicole Handa, et autres
Publié: (2025)

Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
par: Esther H. J. Hamoen, et autres
Publié: (2025)

The carbon footprint of transperineal prostate biopsy
par: Daniel A. Carson, et autres
Publié: (2025)

Robotic retroperitoneal surgery in a uro‐oncology specialised centre: Translating RPLND expertise from testicular cancer to non‐genitourinary retroperitoneal tumour resection
par: Alberto Costa Silva, et autres
Publié: (2026)

Emerging tools for the early detection of prostate cancer
par: Muhammad Haider, et autres
Publié: (2025)

Quality of English‐ and Spanish‐language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities
par: Sophia M. Abusamra, et autres
Publié: (2025)

Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review
par: Abel Tesfai, et autres
Publié: (2024)

Comparing outcomes of Aquablation versus holmium laser enucleation of prostate in the treatment of benign prostatic hyperplasia: A network meta‐analysis
par: Ansh Bhatia, et autres
Publié: (2024)

Contemporary status of diagnostic endoluminal ultrasound and optical coherence tomography in the ureter
par: Samuel Sii, et autres
Publié: (2024)

Bibliometric analysis of focal therapy in prostate cancer research
par: Mohammed Shahait, et autres
Publié: (2024)

‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer
par: Ryan Sutherland, et autres
Publié: (2024)

Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
par: Ailene E. Corona, et autres
Publié: (2026)

The impact of vaporization on adenoma weight in benign prostatic hyperplasia surgery
par: André B. Silva, et autres
Publié: (2026)

Cost‐effectiveness analysis of a biopsy‐free diagnostic strategy for prostate cancer using mpMRI and PSMA‐PET/CT
par: Joshua Yi Min Tung, et autres
Publié: (2026)

Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia
par: Mathew Thakur, et autres
Publié: (2024)

National survey of urologists' views on prostate cancer screening in the United Kingdom
par: Nikhil Mayor, et autres
Publié: (2026)

Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
par: Nadia Rokan, et autres
Publié: (2025)

Multidisciplinary meetings for lower urinary tract symptoms and benign prostate hyperplasia
par: Emilien Seizilles de Mazancourt, et autres
Publié: (2025)

WATER versus WATER II 5‐year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30–80‐cm3 and 80–150‐cm3 prostates
par: Mohamad Baker Berjaoui, et autres
Publié: (2024)

The significant costs of prostate cancer management—An analysis from a Caribbean hospital
par: Geneva Pantoja, et autres
Publié: (2025)

Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
par: Sofia Mesquita, et autres
Publié: (2025)

Evaluating the utility of the HAS‐BLED bleeding‐estimator tool for transurethral resection of prostate
par: Lu Yu Kuo, et autres
Publié: (2025)

Risk factors of negative prostate biopsies: A CHAID decision tree analysis
par: Pierre Allainguillaume, et autres
Publié: (2026)

Analysis of urinary volatile organic compounds for prostate cancer diagnosis: A systematic review
par: Jonathon Dawson, et autres
Publié: (2024)

A machine learning algorithm for automatic tumour board recommendations in prostate cancer patients
par: Marcus Sondermann, et autres
Publié: (2025)

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
par: Arjun Pon Avudaiappan, et autres
Publié: (2024)

Sociodemographic landscape of suspected prostate cancer referrals and diagnoses across North East London
par: Muhammad Haider, et autres
Publié: (2025)

AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
par: Muhammad Imran, et autres
Publié: (2026)

Potential gains from radical treatment of men with prostate cancer according to life expectancy
par: Sandra Irenaeus, et autres
Publié: (2025)

Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm
par: Alan Priester, et autres
Publié: (2024)

Effect of prior HoLEP procedure on multiparametric MRI accuracy in detection of prostate cancer
par: Austin Drysch, et autres
Publié: (2025)